BR0111555A - Piridin-2-ilaminoalquilcarbonilglicil-beta-alanina e derivados - Google Patents
Piridin-2-ilaminoalquilcarbonilglicil-beta-alanina e derivadosInfo
- Publication number
- BR0111555A BR0111555A BR0111555-3A BR0111555A BR0111555A BR 0111555 A BR0111555 A BR 0111555A BR 0111555 A BR0111555 A BR 0111555A BR 0111555 A BR0111555 A BR 0111555A
- Authority
- BR
- Brazil
- Prior art keywords
- ring
- pyridin
- alanine
- derivatives
- ring structures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"PIRIDIN-2-ILAMINOALQUILCARBONILGLICIL-BE-TA-ALANINA E DERIVADOS". A invenção refere-se aos compostos da fórmula I: onde R^ 1^ é H, A, Ar, Hal, -OH, -O-A, CF~ 3~ ou -OCF~ 3~; R^ 2^ e R^ 7^ são H ou A; R^ 3^ é: R^ 4^, R^ 5^ e R^ 6^ são em cada caso, independentemente um do outro, H, A, Hal, -OH, -O-A, -CF~ 3~, -OCF~ 3~, -CN, -NH~ 2~, -A-NH~ 2~; A é C~ 1~-^ (sym)^ .alquila; Ar é um substituinte que é formado por um radical aromático que é opcionalmente substituído uma vez, duas ou três vezes por R^ 5^ e que possui de 1 a 3 estruturas de anel que são opcionalmente fundidas com outras estruturas de anel para formar um sistema de anel fundido; Het é um substituinte que é formado por um heterociclo que possui de 1 a 3 estruturas de anel, com cada estrutura de anel sendo saturada, insaturada ou aromática e sendo opcionalmente fundida com outras estruturas de anel para formar um sistema de anel fundido e o heterociclo possuindo um total de 1 a 4 átomos de N, O e/ou S nas estruturas de anel e sendo opcionalmente substituído por R^ 6^; Hal é F, CI, Br ou I; n é 2, 3, 4, 5 ou 6 e para seu uso.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10028402A DE10028402A1 (de) | 2000-06-13 | 2000-06-13 | Pyridin-2-yl-aminoalkycarbonylglycyl-beta-alanin und Derivate |
| PCT/EP2001/006661 WO2001096365A1 (de) | 2000-06-13 | 2001-06-12 | PYRIDIN-2-YL-AMINOALKYLCARBONYLGLYCYL-β-ALANIN UND DERIVATE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0111555A true BR0111555A (pt) | 2003-07-08 |
Family
ID=7645128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0111555-3A BR0111555A (pt) | 2000-06-13 | 2001-06-12 | Piridin-2-ilaminoalquilcarbonilglicil-beta-alanina e derivados |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030171304A1 (pt) |
| EP (1) | EP1290010A1 (pt) |
| JP (1) | JP2004503562A (pt) |
| KR (1) | KR20030022145A (pt) |
| CN (1) | CN1436196A (pt) |
| AR (1) | AR028714A1 (pt) |
| AU (1) | AU6606301A (pt) |
| BR (1) | BR0111555A (pt) |
| CA (1) | CA2414000A1 (pt) |
| CZ (1) | CZ20023952A3 (pt) |
| DE (1) | DE10028402A1 (pt) |
| HU (1) | HUP0303716A2 (pt) |
| MX (1) | MXPA02012411A (pt) |
| NO (1) | NO20025968L (pt) |
| PL (1) | PL358671A1 (pt) |
| SK (1) | SK17112002A3 (pt) |
| WO (1) | WO2001096365A1 (pt) |
| ZA (1) | ZA200209410B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6455734B1 (en) | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| EA011384B1 (ru) | 1999-06-01 | 2009-02-27 | Байоджен Айдек Ма Инк. | Способ лечения воспалительного заболевания |
| UA83791C2 (ru) | 2001-04-13 | 2008-08-26 | Байоджен Айдек Ма Инк. | Антитело против vla-1, фармацевтическая композиция, которая его содержит, и из применение для лечения индивидуума с иммунологическим расстройством, опосредованным vla-1 |
| US7176322B2 (en) | 2002-05-23 | 2007-02-13 | Amgen Inc. | Calcium receptor modulating agents |
| US6908935B2 (en) | 2002-05-23 | 2005-06-21 | Amgen Inc. | Calcium receptor modulating agents |
| RU2393154C2 (ru) | 2004-03-24 | 2010-06-27 | Йерини Аг | Новые соединения для ингибирования ангиогенеза и их применение |
| EP1789393A2 (en) * | 2004-07-30 | 2007-05-30 | GPC Biotech AG | Pyridinylamines |
| DK2034830T3 (da) | 2006-05-25 | 2014-10-27 | Biogen Idec Inc | Anti-vla-1-antistof til behandling af slagtilfælde |
| CN102224140B (zh) * | 2008-11-24 | 2014-04-16 | 巴斯夫欧洲公司 | 包含热潜性碱的可固化组合物 |
| US10160808B2 (en) | 2012-02-16 | 2018-12-25 | Santarus, Inc. | Anti-VLA1 (CD49A) antibody pharmaceutical compositions |
| CN111526880A (zh) | 2017-11-01 | 2020-08-11 | 箭头药业股份有限公司 | 整联蛋白配体及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199801254T2 (xx) * | 1995-12-29 | 1998-10-21 | Smithkline Beecham Corporation | Vitronektin resept�r� antagonistleri. |
-
2000
- 2000-06-13 DE DE10028402A patent/DE10028402A1/de not_active Withdrawn
-
2001
- 2001-06-12 SK SK1711-2002A patent/SK17112002A3/sk unknown
- 2001-06-12 MX MXPA02012411A patent/MXPA02012411A/es unknown
- 2001-06-12 BR BR0111555-3A patent/BR0111555A/pt not_active Application Discontinuation
- 2001-06-12 EP EP01943499A patent/EP1290010A1/de not_active Withdrawn
- 2001-06-12 CN CN01811104A patent/CN1436196A/zh active Pending
- 2001-06-12 KR KR1020027016894A patent/KR20030022145A/ko not_active Application Discontinuation
- 2001-06-12 US US10/297,989 patent/US20030171304A1/en not_active Abandoned
- 2001-06-12 JP JP2002510506A patent/JP2004503562A/ja active Pending
- 2001-06-12 PL PL01358671A patent/PL358671A1/xx unknown
- 2001-06-12 CZ CZ20023952A patent/CZ20023952A3/cs unknown
- 2001-06-12 WO PCT/EP2001/006661 patent/WO2001096365A1/de not_active Application Discontinuation
- 2001-06-12 HU HU0303716A patent/HUP0303716A2/hu unknown
- 2001-06-12 AU AU66063/01A patent/AU6606301A/en not_active Abandoned
- 2001-06-12 CA CA002414000A patent/CA2414000A1/en not_active Abandoned
- 2001-06-13 AR ARP010102804A patent/AR028714A1/es unknown
-
2002
- 2002-11-19 ZA ZA200209410A patent/ZA200209410B/en unknown
- 2002-12-12 NO NO20025968A patent/NO20025968L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1290010A1 (de) | 2003-03-12 |
| AU6606301A (en) | 2001-12-24 |
| PL358671A1 (en) | 2004-08-09 |
| NO20025968D0 (no) | 2002-12-12 |
| CA2414000A1 (en) | 2002-12-03 |
| US20030171304A1 (en) | 2003-09-11 |
| CZ20023952A3 (cs) | 2003-03-12 |
| DE10028402A1 (de) | 2001-12-20 |
| JP2004503562A (ja) | 2004-02-05 |
| SK17112002A3 (sk) | 2003-04-01 |
| NO20025968L (no) | 2002-12-12 |
| MXPA02012411A (es) | 2003-04-25 |
| WO2001096365A1 (de) | 2001-12-20 |
| KR20030022145A (ko) | 2003-03-15 |
| AR028714A1 (es) | 2003-05-21 |
| CN1436196A (zh) | 2003-08-13 |
| HUP0303716A2 (hu) | 2004-03-01 |
| ZA200209410B (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0111555A (pt) | Piridin-2-ilaminoalquilcarbonilglicil-beta-alanina e derivados | |
| BR9913745A (pt) | Cetonas de piridina úteis como herbicidas | |
| BRPI0518581A2 (pt) | compostos de cromanilurÉia que inibem o receptor do subtipo 1 do recepetor vanilàide (vr1) e usos destes | |
| BR0111667A (pt) | Novos compostos | |
| BR9909808A (pt) | Pirazolopirimidinonas inibidoras de cgmp pde5 para o tratamento da disfunção sexual | |
| BRPI0506629A (pt) | inibição do fator b, a via alternativa do sistema complemento e métodos relacionados | |
| AR052771A1 (es) | Pirimidinas biciclicas inhibidoras del vhc | |
| BR9908757A (pt) | Derivados de 3-hidróxi-4-aril-5-oxopirazolina herbicidamente ativos | |
| BR9814256A (pt) | Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico | |
| BR0116047A (pt) | Imidazoquinolinas substituìdas de éter heterocìclico | |
| BRPI0113146B8 (pt) | "derivados de prolina e composição farmacêutica que os compreende". | |
| BR0107246A (pt) | Agentes diazabicìclicos ativos no sistema nervoso central | |
| DE60231636D1 (de) | Neue difunktionelle fotoinitiatoren | |
| BR9807508A (pt) | Inibidores de sulfamida da metaloprotease | |
| ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| CL2009000512A1 (es) | Compuestos heterociclicos sustituidos derivados de imidazo[4,5-d]piridazina, imidazo[4,5-c]piridazina, imidazo[4,5d]pirimidina, entre otros; composicion farmaceutica que comprende a dichos comppuestos; y uso para tratar el virus de la hepatitis c. | |
| ATE332903T1 (de) | Kondensierte pyridoindolderivate | |
| BRPI0417948A (pt) | derivados de quinuclidina substituìda por bicicloheterociclo fundido | |
| PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| BR0113970A (pt) | Compostos de pirimidina e seu uso | |
| BR0114697A (pt) | Derivados em ponte de piperazina | |
| ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| BR0101492A (pt) | Misturas de pelo menos um enchedor e compostosde organossilìcio, processo para sua preparação eseu uso | |
| BR0316108A (pt) | Derivados de fenilalquil e piridilalquil piperazina e composição farmacêutica compreendendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |